I.3 Remote patient monitoring for movement disorders

Parkinsons disease is one of the 7 most misdiagnosed diseases in the United States and is commonly confused with other movement disorders. Traditionally, neurologists evaluate symptoms in a clinic setting using a task-based protocol along with patient reported symptoms. These evaluations occur when patients are first diagnosed with a movement disorder, after patients have been taking medicine to mitigate symptoms, and after surgical intervention for symptom management called Deep Brain Stimulation (DBS). Therapies, such as Levadopa and DBS, can induce other movement and non-movement related side effects after prolonged use and are commonly misreported to physicians as baseline symptoms. There are currently devices on the market to remotely monitor symptoms of movement disorders, but they were not designed with patient ease of use and simple clinical adoption in mind. Due to current design limitations, there is no widely accepted method for quantitative measurement of these symptoms, resulting in suboptimal pharmaceutical and surgical management. The goal of this project is to create a movement disorder symptom monitor that is applicable to the full lifecycle of movement disorder management, is patient friendly, easy for clinicians to prescribe, and meets current CMS reimbursement guidelines for Remote Patient Monitoring.